Optic neuritis
Tracked across 1 events · 7 articles · First seen Jun 11, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Oculis announced an upcoming presentation at Clinical Trials at the Summit 2026, where its CEO, Riad Sherif, will highlight the development journey of Privosegtor. Privosegtor is a novel peptoid small molecule with the potential to…
Impact: Optic neuritis is a rare condition that Privosegtor aims to treat, representing a significant unmet medical need in ophthalmology.
Jun 11, 2026 · 7 articles
NEWSDESK
Track Optic neuritis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard